-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Eledon Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
- Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.78M, a 2.83% increase year-over-year.
- Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.25M, a 30.8% increase year-over-year.
- Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.55M, a 19.7% decline from 2022.
- Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.15M, a 3.15% increase from 2021.
- Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.9M, a 149% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)